| Literature DB >> 30179235 |
Mojtaba Masoudi1, Hamid-Reza Pourreza1, Mahdi Saadatmand-Tarzjan2, Noushin Eftekhari1, Fateme Shafiee Zargar3, Masoud Pezeshki Rad3.
Abstract
The lack of publicly available datasets of computed-tomography angiography (CTA) images for pulmonary embolism (PE) is a problem felt by physicians and researchers. Although a number of computer-aided detection (CAD) systems have been developed for PE diagnosis, their performance is often evaluated using private datasets. In this paper, we introduce a new public dataset called FUMPE (standing for Ferdowsi University of Mashhad's PE dataset) which consists of three-dimensional PE-CTA images of 35 different subjects with 8792 slices in total. For each benchmark image, two expert radiologists provided the ground-truth with the assistance of a semi-automated image processing software tool. FUMPE is a challenging benchmark for CAD methods because of the large number (i.e., 3438) of PE regions and, more especially, because of the location of most of them (i.e., 67%) in lung peripheral arteries. Moreover, due to the reporting of the Qanadli score for each PE-CTA image, FUMPE is the first public dataset which can be used for the analysis of mortality and morbidity risks associated with PE. We also report some complementary prognosis information for each subject.Entities:
Mesh:
Year: 2018 PMID: 30179235 PMCID: PMC6122162 DOI: 10.1038/sdata.2018.180
Source DB: PubMed Journal: Sci Data ISSN: 2052-4463 Impact factor: 6.444
Figure 1Five steps of the development process of the proposed dataset.
Different characteristics of CTA images reported in FUMPE.
| Including the subject gender and age, deep vein thrombosis (DVT) test, slice thickness and interval, tube current, imaging direction, total number of slices (#Slice), total number of regions of interest with pulmonary embolism (#PE-ROIs) in main arteries, #PE-ROIs in peripheral arteries, and #PE-ROIs in the total arteries. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient01 | M | 32 | X | 1.0 (1.0) | [198, 297] | Caudocranial | 201 | 46 | 34 | 80 |
| Patient02 | F | 70 | ✓ | 1.0 (1.0) | [123, 155] | Caudocranial | 185 | 0 | 21 | 21 |
| Patient03 | M | 42 | NA | 1.0 (4.0) | [210, 282] | Caudocranial | 210 | 39 | 55 | 94 |
| Patient04 | F | 70 | X | 1.0 (1.0) | [183, 239] | Caudocranial | 197 | 17 | 29 | 46 |
| Patient05 | F | NR | NA | 1.0 (1.0) | [147, 210] | Caudocranial | 217 | 71 | 92 | 163 |
| Patient06 | F | NR | NA | 1.0 (1.0) | [135, 167] | Caudocranial | 232 | 0 | 15 | 15 |
| Patient07 | M | 52 | ✓ | 1.0 (1.0) | [196, 251] | Caudocranial | 197 | 95 | 147 | 242 |
| Patient08 | M | 28 | ✓ | 1.0 (1.0) | [160, 257] | Caudocranial | 273 | 23 | 36 | 59 |
| Patient09 | F | 69 | NA | 1.0 (1.0) | [124, 184] | Caudocranial | 237 | 0 | 53 | 53 |
| Patient10 | M | 71 | NA | 1.0 (4.0) | [142, 224] | Caudocranial | 204 | 0 | 8 | 8 |
| Patient11 | F | 63 | NA | 1.0 (1.0) | [60, 87] | Caudocranial | 217 | 0 | 18 | 18 |
| Patient12 | F | 71 | ✓ | 1.0 (1.0) | [130, 160] | 178 | 0 | 77 | 77 | |
| Patient13 | M | 27 | ✓ | 1.0 (1.0) | [235, 303] | Caudocranial | 189 | 30 | 23 | 53 |
| Patient14 | F | 29 | NA | 1.0 (1.0) | [231, 281] | Caudocranial | 217 | 0 | 98 | 98 |
| Patient15 | M | 61 | ✓ | 1.0 (1.0) | [145, 204] | Caudocranial | 250 | 15 | 31 | 46 |
| Patient16 | F | 53 | NA | 1.0 (1.0) | [142, 236] | Caudocranial | 235 | 18 | 59 | 77 |
| Patient17 | F | 62 | ✓ | 1.0 (0.5) | [232, 325] | Caudocranial | 475 | 194 | 60 | 254 |
| Patient18 | M | 82 | ✓ | 1.0 (0.5) | [165, 295] | Caudocranial | 452 | 54 | 102 | 156 |
| Patient19 | M | 76 | NA | 1.0 (1.0) | [206, 266] | Caudocranial | 370 | 51 | 300 | 351 |
| Patient20 | M | 39 | NA | 1.0 (0.5) | [168, 321] | Caudocranial | 424 | 19 | 48 | 67 |
| Patient21 | M | 80 | NA | 1.0 (1.0) | 242 | Caudocranial | 217 | 51 | 0 | 51 |
| Patient22 | F | 80 | NA | 1.0 (1.0) | [174, 246] | Caudocranial | 185 | 0 | 22 | 22 |
| Patient23 | M | 54 | ✓ | 1.0 (1.0) | [199, 276] | Caudocranial | 297 | 0 | 116 | 116 |
| Patient24 | F | 31 | NA | 2.0 (1.5) | [121, 175] | Caudocranial | 139 | 0 | 0 | 0 |
| Patient25 | F | 33 | NA | 1.0 (1.0) | [184, 285] | Caudocranial | 221 | 0 | 67 | 67 |
| Patient26 | F | 24 | NA | 1.0 (1.0) | [134, 283] | Caudocranial | 213 | 77 | 131 | 208 |
| Patient27 | M | 28 | ✓ | 1.0 (1.0) | [107, 207] | Caudocranial | 277 | 53 | 88 | 141 |
| Patient28 | F | 31 | ✓ | 1.0 (4.0) | [182, 264] | Caudocranial | 183 | 19 | 0 | 19 |
| Patient29 | M | 70 | NA | 1.0 (1.0) | [152, 203] | Caudocranial | 197 | 24 | 72 | 96 |
| Patient30 | F | 77 | ✓ | 1.0 (1.0) | [120, 228] | Caudocranial | 205 | 35 | 64 | 99 |
| Patient31 | M | 70 | ✓ | 1.0 (1.0) | [144, 227] | 268 | 54 | 103 | 157 | |
| Patient32 | F | 74 | NA | 2.0 (1.5) | [106, 132] | Caudocranial | 155 | 0 | 0 | 0 |
| Patient33 | F | 72 | ✓ | 1.0 (0.5) | [192, 277] | Caudocranial | 435 | 115 | 60 | 175 |
| Patient34 | M | 80 | NA | 1.0 (1.0) | [182, 279] | Caudocranial | 189 | 34 | 121 | 155 |
| Patient35 | M | 66 | NA | 1.0 (0.5) | [217, 328] | Caudocranial | 451 | 0 | 154 | 154 |
| Total | 8792 | 1134 (33%) | 2304 (67%) | 3438 |
Figure 2Sample Q-Score computation.
The arterial segments of the left and right lungs of Patient16 (used for Q-score computation) are illustrated as an example. The obstruction index of each segment is indicated in the figure. The total Q-score (i.e. 19) was computed as the superposition of all the obstruction indices.
Figure 3A sample CTA image of FUMPE.
Including the source (left-hand side in each pair) and ground-truth (right-hand side in the same pair) images corresponding to the (a) 77th, (b) 80th, (c) 106th, (d) 116th, (e) 119th, (f) 133th, (g) 139th, and (h) 151th slices of Patient16.
Five different measurements reported for each CTA image of FUMPE.
| Including the ratio of right ventricular to left ventricular diameter (RV/LV ratio), reflux into the inferior vena cava (IVC), straight septum, pulmonary artery (PA) diameter, and Qanadli score (Q-Score). | |||||
|---|---|---|---|---|---|
| Patient01 | 0.86 (=31/35) | X | X | 33 | 20 |
| Patient02 | 1.13 (=27/24) | ✓ | X | 24 | 1 |
| Patient03 | 1.03 (=33/32) | X | ✓ | 33 | 20 |
| Patient04 | 1.33 (=24/18) | ✓ | ✓ | 31 | 29 |
| Patient05 | 0.89 (=42/47) | X | X | 28 | 20 |
| Patient06 | 1.03 (=31/30) | ✓ | X | 38 | 3 |
| Patient07 | 2.00 (=40/20) | ✓ | ✓ | 31 | 31 |
| Patient08 | 1.04 (=25/24) | X | X | 30 | 7 |
| Patient09 | 1.18 (=20/17) | ✓ | X | 30 | 4 |
| Patient10 | 0.78 (=21/27) | X | X | 26 | 7 |
| Patient11 | 0.72 (=23/32) | X | X | 27 | 2 |
| Patient12 | 0.75 (=24/32) | X | X | 28 | 6 |
| Patient13 | 0.65 (=20/31) | ✓ | ✓ | 27 | 14 |
| Patient14 | 0.73 (=22/30) | ✓ | X | 25 | 8 |
| Patient15 | 0.87 (=27/31) | X | X | 24 | 8 |
| Patient16 | 1.65 (=28/17) | ✓ | ✓ | 28 | 19 |
| Patient17 | 1.46 (=41/28) | ✓ | ✓ | 37 | 20 |
| Patient18 | 1.19 (=25/21) | ✓ | X | 22 | 12 |
| Patient19 | 1.47 (=22/15) | ✓ | X | 24 | 16 |
| Patient20 | 0.75 (=12/16) | X | X | 19 | 5 |
| Patient21 | 1.56 (=67/43) | ✓ | ✓ | 36 | 10 |
| Patient22 | 0.93 (=27/29) | X | X | 28 | 3 |
| Patient23 | 1.12 (=28/25) | ✓ | ✓ | 41 | 17 |
| Patient24 | 0.97 (=38/39) | ✓ | X | 25 | 0 |
| Patient25 | 0.40 (=19/48) | X | X | 31 | 3 |
| Patient26 | 1.65 (=28/17) | ✓ | ✓ | 32 | 27 |
| Patient27 | 0.81 (=17/21) | X | X | 20 | 18 |
| Patient28 | 0.59 (=23/39) | ✓ | X | 25 | 7 |
| Patient29 | 1.30 (=39/30) | ✓ | ✓ | 27 | 22 |
| Patient30 | 0.63 (=25/40) | X | X | 32 | 7 |
| Patient31 | 1.19 (=32/27) | ✓ | X | 23 | 20 |
| Patient32 | 1.21 (=34/28) | ✓ | X | 28 | 0 |
| Patient33 | 1.33 (=20/15) | ✓ | ✓ | 26 | 14 |
| Patient34 | 1.94 (=35/18) | ✓ | ✓ | 27 | 22 |
| Patient35 | 0.91 (=29/32) | X | X | 26 | 9 |
Figure 4The Q-score histogram of FUMPE.
Comparing FUMPE with 14 different PE-CTA datasets.
| In terms of the number of subjects (#Subjects), number of clots (#Clots), number of regions of interest with pulmonary embolism (#PE-ROIs), public accessibility, available scoring, and prognosis information. | ||||||
|---|---|---|---|---|---|---|
| Masutani et al.[ | 11 | 21 | − | X | X | X |
| Pichon et al.[ | 3 | 22 | − | X | X | X |
| Das et al.[ | 33 | 168 | − | X | X | X |
| Digumarthy et al.[ | 39 | 270 | − | X | X | X |
| Maizlin et al.[ | 8 | 45 | − | X | X | X |
| Kiraly et al.[ | 8 | 69 | − | X | X | X |
| Zhou et al.[ | 14 | 225 | − | X | X | X |
| Buhmann et al.[ | 40 | 352 | − | X | X | X |
| Wittenberg et al.[ | 119 | 38 | − | X | X | X |
| Bouma et al.[ | 19 | 116 | − | X | X | X |
| Özkan et al.[ | 33 | 450 | − | X | X | X |
| Park et al.[ | 20 | 44 | 648 | X | X | X |
| Tajbakhsh et al.[ | 121 | 326 | − | X | X | X |
| m+visión[ | 20 | 105 | 5521 | ✓ | X | X |
| FUMPE | 35 | 119 | 3438 | ✓ | Q-score | DVT Test, RV/LV Ratio, Reflux into IVC, Straight Septum, PA Diameter |